The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
Authors
Keywords
-
Journal
European Respiratory Review
Volume 29, Issue 157, Pages 200269
Publisher
European Respiratory Society (ERS)
Online
2020-10-16
DOI
10.1183/16000617.0269-2020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways
- (2020) Debra Dorotea et al. Frontiers in Pharmacology
- Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism
- (2019) Rebecca Bertolio et al. Nature Communications
- A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
- (2019) Pauline T. Lukey et al. EUROPEAN RESPIRATORY JOURNAL
- Activation of mTORC1/PGC1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium
- (2019) Ross Summer et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β1–induced collagen biosynthesis
- (2019) Brintha Selvarajah et al. Science Signaling
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
- (2019) Boris Hinz et al. Nature Reviews Rheumatology
- Glutaminolysis Promotes Collagen Translation and Stability via α-Ketoglutarate–mediated mTOR Activation and Proline Hydroxylation
- (2018) Jing Ge et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Fatty acid synthase is required for profibrotic TGF-β signaling
- (2018) Mi-Yeon Jung et al. FASEB JOURNAL
- A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
- (2018) Sarah J. Mahoney et al. Nature Communications
- Glutaminolysis Epigenetically Regulates Anti-Apoptotic Gene Expression in IPF Fibroblasts
- (2018) Le Bai et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
- (2018) Hannah V. Woodcock et al. Nature Communications
- Glutaminolysis is required for transforming growth factor-β1–induced myofibroblast differentiation and activation
- (2017) Karen Bernard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular senescence mediates fibrotic pulmonary disease
- (2017) Marissa J. Schafer et al. Nature Communications
- mTORC1 activation decreases autophagy in aging and idiopathic pulmonary fibrosis and contributes to apoptosis resistance in IPF fibroblasts
- (2016) Yair Romero et al. AGING CELL
- Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
- (2016) Paul F Mercer et al. THORAX
- Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
- (2015) Na Xie et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs
- (2015) Cheresa Calhoun et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
- (2015) Remi-Martin Laberge et al. NATURE CELL BIOLOGY
- Differential regulation of mTORC1 by leucine and glutamine
- (2015) J. L. Jewell et al. SCIENCE
- Regulation of TORC1 in Response to Amino Acid Starvation via Lysosomal Recruitment of TSC2
- (2014) Constantinos Demetriades et al. CELL
- The burden of idiopathic pulmonary fibrosis: An unmet public health need
- (2014) Augustine S. Lee et al. RESPIRATORY MEDICINE
- Strategies for the management of adverse events associated with mTOR inhibitors
- (2014) Bruce Kaplan et al. Transplantation Reviews
- mTOR kinase inhibitors as potential cancer therapeutic drugs
- (2013) Shi-Yong Sun CANCER LETTERS
- Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
- (2013) Thida Win et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin
- (2013) S. A. Kang et al. SCIENCE
- The myofibroblast matrix: implications for tissue repair and fibrosis
- (2012) Franco Klingberg et al. JOURNAL OF PATHOLOGY
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis
- (2011) MONIQUE A. MALOUF et al. RESPIROLOGY
- Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
- (2010) Yasemin Sancak et al. CELL
- Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice
- (2010) Remo C. Russo et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
- (2010) Calvin K. Yip et al. MOLECULAR CELL
- A complex interplay between Akt, TSC2 and the two mTOR complexes: Figure 1
- (2009) Jingxiang Huang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Non-Smad pathways in TGF-β signaling
- (2008) Ying E Zhang CELL RESEARCH
- Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis
- (2008) Hong Xia et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now